Samaha Frederick F, Kahn Mark L
Department of Medicine and Division of Cardiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2588-93. doi: 10.1161/01.ATV.0000248734.89782.37. Epub 2006 Oct 5.
The immunoreceptor signaling pathway has classically been defined by its role in mediating intracellular signals downstream of immune receptors on circulating cells, but recent studies have revealed new and unexpected roles for this pathway in vascular biology. In platelets the immunoreceptor signaling pathway is coupled to 2 structurally distinct platelet collagen receptors, glycoprotein VI and integrin alpha2beta1, and is required for the activation of platelets after exposure to vessel wall collagen during plaque rupture. During vascular development immunoreceptor signaling is required for proper formation of the lymphatic system, a role that has revealed the contribution of hematopoietic endothelial progenitors to that process. In conjunction with the identification of new biological roles in vascular cell types, new molecular mechanisms of activating this signaling pathway have been discovered, including activation by integrins and immunoreceptor tyrosine activation motifs (ITAMs) on receptors that do not function as part of the immune response. Here we discuss some of these recent findings and their implications for vascular biology and the treatment of human vascular diseases.
免疫受体信号通路传统上是根据其在介导循环细胞上免疫受体下游的细胞内信号中的作用来定义的,但最近的研究揭示了该通路在血管生物学中的新的意外作用。在血小板中,免疫受体信号通路与两种结构不同的血小板胶原受体——糖蛋白VI和整合素α2β1偶联,并且在斑块破裂期间暴露于血管壁胶原后激活血小板是必需的。在血管发育过程中,免疫受体信号对于淋巴系统的正常形成是必需的,这一作用揭示了造血内皮祖细胞对该过程的贡献。随着在血管细胞类型中发现新的生物学作用,人们还发现了激活该信号通路的新分子机制,包括整合素和受体上的免疫受体酪氨酸激活基序(ITAM)的激活,而这些受体并非作为免疫反应的一部分发挥作用。在此,我们讨论其中一些最新发现及其对血管生物学和人类血管疾病治疗的意义。